<DOC>
	<DOC>NCT02837640</DOC>
	<brief_summary>The purpose of this study is to evaluate the effect of L-Dopa on the progression of retinitis pigmentosa.</brief_summary>
	<brief_title>Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa</brief_title>
	<detailed_description>Retinitis pigmentosa is a group of progressive hereditary diseases that diffusely affects the functioning of photoreceptors and the pigment epithelium. It may be speculated that a protective effect on the pigment epithelium, as it is supposed for L-Dopa, can slow the progression of the disease or even lead to an, at least transient, improvement of visual functions. To evaluate the effect of L-Dopa on retinitis pigmentosa progression, visual acuity, electroretinogram and visual field will be preformed regularly.</detailed_description>
	<mesh_term>Retinitis</mesh_term>
	<mesh_term>Retinitis Pigmentosa</mesh_term>
	<mesh_term>Carbidopa</mesh_term>
	<mesh_term>Carbidopa, levodopa drug combination</mesh_term>
	<mesh_term>Levodopa</mesh_term>
	<criteria>All confirmed cases of retinitis pigmentosa VA of 20/400 or better Advanced stages of retinitis pigmentosa with poor best corrected visual acuity (less than 20/400) coexisting eye morbidities interfering with retinitis pigmentosa (glaucoma, retinal detachment...) Flat electroretinogram Intolerance or counterindication to drug Unability for longterm followup</criteria>
	<gender>All</gender>
	<minimum_age>10 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>Retinitis Pigmentosa</keyword>
	<keyword>Levodopa</keyword>
</DOC>